ChemicalBook >> journal list >> Small Methods >>article
Small Methods

Small Methods

IF: 10.7
Download PDF

Characterization of Cancer Cell Mechanics by Measuring Active Deformation Behavior

Published:29 September 2023 DOI: 10.1002/smtd.202300520 PMID: 37775303
Jiantao Feng, Quanmei Sun, Peipei Chen, Keli Ren, Yuanyuan Zhang, Yahong Shi, Songkun Gao, Zhiwei Song, Jigang Wang, Fulong Liao, Dong Han

Abstract

Active deformation behavior reflects cell structural dynamics adapting to varying environmental constraints during malignancy progression. In most cases, cell mechanics is characterized by modeling using static equilibrium systems, which fails to comprehend cell deformation behavior leading to inaccuracies in distinguishing cancer cells from normal cells. Here, a method is introduced to measure the active deformation behavior of cancer cells using atomic force microscopy (AFM) and the newly developed deformation behavior cytometry (DBC). During the measurement, cells are deformed and allows a long timescale relaxation (≈5 s). Two parameters are derived to represent deformation behavior: apparent Poisson's ratio for adherent cells, which is measured with AFM and refers to the ratio of the lateral strain to the longitudinal strain of the cell, and shape recovery for suspended cells, which is measured with DBC. Active deformation behavior defines cancer cell mechanics better than traditional mechanical parameters (e.g., stiffness, diffusion, and viscosity). Additionally, aquaporins are essential for promoting the deformation behavior, while the actin cytoskeleton acts as a downstream effector. Therefore, the potential application of the cancer cell active deformation behavior as a biomechanical marker or therapeutic target in cancer treatment should be evaluated.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Bacopaside II 382146-66-9 C47H76O18 100 suppliers $85.00-$996.00
Bacopaside II 382146-66-9 C47H76O18 100 suppliers $85.00-$996.00
Bacopaside II 382146-66-9 C47H76O18 100 suppliers $85.00-$996.00
Bacopaside II 382146-66-9 C47H76O18 100 suppliers $85.00-$996.00

Similar articles

IF:12.7

Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.

ACS Central Science Sabrina Baltschukat, Barbara Schacher Engstler,etc Published: 15 May 2019
IF:5.3

Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.

ACS Applied Nano Materials Ruma Maji, Niladri Shekhar Dey,etc Published: 25 June 2014